TFRC and plasma cell myeloma: Specifically, using a technique exploiting an anti-CD38 nanobody-based photoaffinity labeling, they discovered that cell surface CD38 interacts with the transferrin receptor CD71 and that the CD38-CD71 complex is present naturally in the myeloma cell line LP-1 [42].